Details
Stereochemistry | ACHIRAL |
Molecular Formula | C35H32N6O4 |
Molecular Weight | 600.6664 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC2=CN=CC=C2N1CC3CCN(CC3)C(=O)\C=C(\C4=CC=CC=C4)C5=CC=C(C=C5)\N=N\C6=CC(C(O)=O)=C(O)C=C6
InChI
InChIKey=AYEAMZDTWLXZIJ-RKOUKRECSA-N
InChI=1S/C35H32N6O4/c1-23-37-31-21-36-16-13-32(31)41(23)22-24-14-17-40(18-15-24)34(43)20-29(25-5-3-2-4-6-25)26-7-9-27(10-8-26)38-39-28-11-12-33(42)30(19-28)35(44)45/h2-13,16,19-21,24,42H,14-15,17-18,22H2,1H3,(H,44,45)/b29-20-,39-38+
Molecular Formula | C35H32N6O4 |
Molecular Weight | 600.6664 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
Dersalazine is a locally-acting compound. It is a potent platelet activating factor (PAF)-antagonist. Dersalazine inhibited IL-1beta or TNF-alpha production in THP-1 or U937 cells, respectively. Dersalazine sodium reduced colonic proinflammatory cytokines IL-1b, IL-6, and IL-17 in dextran sodium sulphate (DSS)–induced colitis. After oral administration, dersalazine sodium is mostly unabsorbed until it reaches the large bowel where the azo bond is reduced by bacteria releasing the active compound. Dersalazine had been in phase I clinical trial for the treatment of ulcerative colitis. No serious adverse reactions were detected in clinical trial. However, no recent development has been reported.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25192498
1200 mg/12 h for 4 weeks
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:28:42 GMT 2025
by
admin
on
Wed Apr 02 08:28:42 GMT 2025
|
Record UNII |
WS1IH75AJT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C308
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8194
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
PRIMARY | |||
|
WS1IH75AJT
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
PRIMARY | |||
|
9808813
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
PRIMARY | |||
|
188913-58-8
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
PRIMARY | |||
|
DB06251
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
PRIMARY | |||
|
300000034116
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106406
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
PRIMARY | |||
|
C77949
Created by
admin on Wed Apr 02 08:28:42 GMT 2025 , Edited by admin on Wed Apr 02 08:28:42 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
||
|
ACTIVE MOIETY |
|